154 related articles for article (PubMed ID: 7296904)
1. Blood-spot 17 alpha-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia.
Sólyom J
Clin Endocrinol (Oxf); 1981 Jun; 14(6):547-53. PubMed ID: 7296904
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay of blood-spot 17 alpha-hydroxyprogesterone in the management of congenital adrenal hyperplasia.
Robinson JA; Dyas J; Hughes IA; Riad-Fahmy D
Ann Clin Biochem; 1987 Jan; 24 ( Pt 1)():58-65. PubMed ID: 3827186
[TBL] [Abstract][Full Text] [Related]
3. Bloodspot 17 alpha-hydroxyprogesterone radioimmunoassay for diagnosis of congenital adrenal hyperplasia and home monitoring of corticosteroid replacement therapy.
Riordan FA; Wood PJ; Wakelin K; Betts P; Clayton BE
Lancet; 1984 Mar; 1(8379):708-11. PubMed ID: 6143043
[TBL] [Abstract][Full Text] [Related]
4. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
Arisaka O; Shimura N; Nakayama Y; Arisaka M; Yabuta K
Dtsch Med Wochenschr; 1988 Dec; 113(49):1913-5. PubMed ID: 3197614
[TBL] [Abstract][Full Text] [Related]
5. "Dot-17 alpha-hydroxyprogesterone" radioimmunoassay for identification of congenital adrenal hyperplasia in young infants.
Sólyom J; Hervei S; Marossy P; Sólyom E; Babosa M; Szombathy G
Acta Paediatr Scand; 1981 Nov; 70(6):913-7. PubMed ID: 7324946
[TBL] [Abstract][Full Text] [Related]
6. Blood-spot 17-hydroxyprogesterone daily profiles in infants with congenital adrenal hyperplasia.
Sólyom J; Hosszu E; Gács G
Exp Clin Endocrinol; 1990 Sep; 96(1):52-6. PubMed ID: 2279525
[TBL] [Abstract][Full Text] [Related]
7. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
Santos CM; Abad LR; Cua SC; Domingo CF
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():174-8. PubMed ID: 15906729
[TBL] [Abstract][Full Text] [Related]
8. Screening for congenital adrenal hyperplasia: distribution of 17 alpha-hydroxyprogesterone concentrations in neonatal blood spot specimens.
Thompson R; Seargeant L; Winter JS
J Pediatr; 1989 Mar; 114(3):400-4. PubMed ID: 2784166
[TBL] [Abstract][Full Text] [Related]
9. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Shibata Y
Nihon Naibunpi Gakkai Zasshi; 1991 Aug; 67(8):819-39. PubMed ID: 1813324
[TBL] [Abstract][Full Text] [Related]
10. Monitoring steroid replacement therapy in children with congenital adrenal hyperplasia.
Birkebaek NH; Hougaard DM; Cohen AS
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):85-88. PubMed ID: 27977405
[TBL] [Abstract][Full Text] [Related]
11. Home monitoring of 17 alpha-hydroxyprogesterone levels by filter paper blood spots in patients with 21-hydroxylase deficiency.
Shimon I; Kaiserman I; Sack J
Horm Res; 1995; 44(6):247-52. PubMed ID: 8808009
[TBL] [Abstract][Full Text] [Related]
12. Correlation of blood-spot 17-hydroxyprogesterone daily profiles and urinary steroid profiles in congenital adrenal hyperplasia.
Erhardt E; Sólyom J; Homoki J; Juricskay S; Soltész G
J Pediatr Endocrinol Metab; 2000 Feb; 13(2):205-10. PubMed ID: 10711668
[TBL] [Abstract][Full Text] [Related]
13. Urinary 17 alpha-hydroxyprogesterone in management of 21-hydroxylase deficiency.
Lim YJ; Yong AB; Warne GL; Montalto J
J Paediatr Child Health; 1995 Feb; 31(1):47-50. PubMed ID: 7748691
[TBL] [Abstract][Full Text] [Related]
14. Serum 17 alpha-hydroxyprogesterone in infants and children as measured by a direct radioimmunoassay kit.
Lee A; Ellis G
Clin Biochem; 1991 Dec; 24(6):505-11. PubMed ID: 1773491
[TBL] [Abstract][Full Text] [Related]
15. Enzyme immunoassay of 17-hydroxyprogesterone in plasma, microfilter paper blood and saliva of newborns, children and patients with congenital adrenal hyperplasia.
Hubl W; Fehér T; Rohde W; Dörner G; Taubert H; Freymann E
Endokrinologie; 1982 Jun; 79(2):165-72. PubMed ID: 6751805
[TBL] [Abstract][Full Text] [Related]
16. Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia.
Atherden SM; Barnes ND; Grant DB
Arch Dis Child; 1972 Aug; 47(254):602-4. PubMed ID: 5046776
[TBL] [Abstract][Full Text] [Related]
17. 17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.
von Schnakenburg K; Bidlingmaier F; Knorr D
Eur J Pediatr; 1980 May; 133(3):259-67. PubMed ID: 7389739
[TBL] [Abstract][Full Text] [Related]
18. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
Otten BJ; Wellen JJ; Rijken JC; Stoelinga GB; Benraad TJ
J Clin Endocrinol Metab; 1983 Dec; 57(6):1150-4. PubMed ID: 6605355
[TBL] [Abstract][Full Text] [Related]
19. Age of appearance of circadian rhythm in blood 17-hydroxyprogesterone in 21-hydroxylase deficiency.
Sólyom J
Acta Physiol Hung; 1991; 78(2):107-10. PubMed ID: 1808976
[TBL] [Abstract][Full Text] [Related]
20. [Neonatal mass-screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. I. Microfilter paper methods for radioimmunoassay of 17 alpha-hydroxyprogesterone].
Shimozawa K
Nihon Naibunpi Gakkai Zasshi; 1983 Dec; 59(12):1845-9. PubMed ID: 6609091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
